Previous close | 0.0600 |
Open | 0.1000 |
Bid | 0.0500 |
Ask | 0.1000 |
Strike | 1.00 |
Expiry date | 2025-01-17 |
Day's range | 0.0900 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 8.21k |
Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.
Despite a net loss, Senseonics reports revenue growth and significant strategic collaborations in the first quarter of 2024.
GERMANTOWN, Md., May 13, 2024--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2024.